See up to 3 months of CDRE. The 7-day demo opens the 1M and 3M ranges and puts CDRE on your watchlist.
Start 7-day demoLatest CDRE insider trades
About Cadre Holdings, Inc. (CDRE)
Cadre Holdings, Inc. is an SEC registrant, filing under CIK 0001860543, classified as orthopedic, prosthetic and surgical appliances and supplies. We track it alongside the rest of the Health Care sector.
CDRE Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 6 | 288,742 | $9.47M |
| Option exercise | 4 | 177,484 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
CDRE insider transactions (Form 4)
2846 Form 4 filings on record, the earliest from Nov 13, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Deborah A. Decotis - Director | Grant or award | Stock Option (right to purchase) | 16,000 | $0.00 | - | |
| Warren B. Kanders - Officer | Open-market sale | Common Stock, par value $0.0001 per share ("Common Stock") | 12,133 | $36.22 | $439K | |
| Warren B. Kanders - Officer | Open-market sale | Common Stock, par value $0.0001 per share ("Common Stock") | 25,000 | $35.29 | $882K | |
| Warren B. Kanders - Officer | Open-market sale | Common Stock, par value $0.0001 per share ("Common Stock") | 25,000 | $35.32 | $883K | |
| Warren B. Kanders - Officer | Open-market sale | Common Stock, par value $0.0001 per share ("Common Stock") | 25,000 | $35.49 | $887K | |
| Warren B. Kanders - Officer | Open-market sale | Common Stock | 25,000 | $35.05 | $876K | |
| Warren B. Kanders - Officer | Open-market sale | Common Stock, par value $0.0001 per share ("Common Stock") | 25,000 | $35.83 | $896K | |
| Warren B. Kanders - Officer | Open-market sale | Common Stock | 25,000 | $35.67 | $892K | |
| Brad Williams - Officer | Open-market sale | Common Stock, par value $0.0001 per share ("Common Stock") | 25,000 | $34.24 | $856K | |
| Warren B. Kanders - Officer | Open-market sale | Common Stock, par value $0.0001 per share ("Common Stock") | 25,589 | $34.20 | $875K | |
| Warren B. Kanders - Officer | Open-market sale | Common Stock | 50,000 | $34.24 | $1.71M | |
| Nicolas Sokolow - Director | Open-market sale | Common Stock, $.0001 par value ("Common Stock") | 839 | $33.75 | $28K | |
| Nicolas Sokolow - Director | Open-market sale | Common Stock | 823 | $33.75 | $28K | |
| Nicolas Sokolow - Director | Open-market sale | Common Stock | 10,000 | $33.78 | $338K | |
| Nicolas Sokolow - Director | Open-market sale | Common Stock | 4,089 | $34.08 | $139K | |
| Nicolas Sokolow - Director | Open-market sale | Common Stock | 3,154 | $34.08 | $107K | |
| Warren B. Kanders - Officer | Open-market sale | Common Stock, par value $0.0001 per share ("Common Stock") | 49,411 | $33.56 | $1.66M | |
| Warren B. Kanders - Officer | Open-market sale | Common Stock, par value $0.0001 per share ("Common Stock") | 50,000 | $33.55 | $1.68M | |
| Nicolas Sokolow - Director | Open-market sale | Common Stock, $.0001 par value ("Common Stock") | 5,000 | $33.25 | $166K | |
| Nicolas Sokolow - Director | Open-market sale | Common Stock | 72 | $34.10 | $2K | |
| Nicolas Sokolow - Director | Open-market sale | Common Stock | 1,023 | $34.10 | $35K | |
| Warren B. Kanders - Officer | Open-market sale | Common Stock, par value $0.0001 per share ("Common Stock") | 50,000 | $32.77 | $1.64M | |
| Warren B. Kanders - Officer | Open-market sale | Common Stock | 50,000 | $33.25 | $1.66M | |
| Warren B. Kanders - Officer | Open-market sale | Common Stock, par value $0.0001 per share ("Common Stock") | 42,036 | $32.00 | $1.35M | |
| Warren B. Kanders - Officer | Open-market sale | Common Stock | 25,000 | $32.29 | $807K | |
| Warren B. Kanders - Officer | Open-market sale | Common Stock, par value $0.0001 per share ("Common Stock") | 50,000 | $32.68 | $1.63M | |
| Warren B. Kanders - Officer | Open-market sale | Common Stock | 7,964 | $32.09 | $256K | |
| Blaine Browers - Officer | Open-market sale | Common Stock, par value $.0001 per share ("Common Stock") | 30,000 | $34.06 | $1.02M |
Recent CDRE Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Warren B. Kanders | Officer, Director, 10% Shareholder | 100,000 | $3.19M | View on EDGAR | |
| Warren B. Kanders | Officer, Director, 10% Shareholder | 100,000 |
Stock trades in CDRE disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Gilbert Ray Cisneros, Jr.Democrat, CA-31 | Purchase |
CDRE insider trading FAQ
What is the latest insider trade for CDRE?
Cadre Holdings, Inc. (CDRE) had 2 insider filings in the last 90 days, with the most recent on 2026-08-26. The full record for CDRE runs to 46 Form 4 filings, the earliest from 2024-11-13. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CDRE stock?
No insider purchases of CDRE were filed in the last 90 days.
How many insiders are selling CDRE stock?
6 insider sales of CDRE were filed in the last 90 days, totaling $9.47M.
Where can I see CDRE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CDRE Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Warren B. Kanders view on EDGAR
- - Brad Williams view on EDGAR
- - Warren B. Kanders view on EDGAR
- - Mary E. Kissel view on EDGAR
- - William G. Quigley III view on EDGAR
- - Hamish Norton view on EDGAR
- - Nicolas Sokolow view on EDGAR
- - Blaine Browers view on EDGAR
- - Brad Williams view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where CDRE's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CDRE with a 7-day demo
- CDRE on your watchlist
- Every CDRE Form 4 filing on record
- Up to 3 months of CDRE price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
